Biosenta Inc. (CSE:ZRO)

Biosenta Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 18, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	3	4	3	11	9	10
Market Cap Growth	-68.44%	41.45%	-74.12%	20.34%	-10.28%	111.55%
Enterprise Value	10	10	8	13	11	11
Last Close Price	0.08	0.12	0.09	0.42	0.40	0.53
PS Ratio	3058.40	3352.41	2081.22	10643.73	8006.95	61.11
PB Ratio	-0.27	-0.40	-0.36	-1.41	-3.15	-3.96
EV/Sales Ratio	-	8604.98	5968.53	12587.90	9132.86	67.33
Debt / Equity Ratio	-0.65	-0.66	-0.70	-0.71	-0.56	-0.46
Net Debt / Equity Ratio	-0.65	-0.66	-0.70	-0.71	-0.55	-0.42
Net Debt / EBITDA Ratio	-5.49	-5.38	-5.04	-	-	-
Net Debt / FCF Ratio	-15.47	-13.73	-7.11	-9.91	-3.17	-1.63
Asset Turnover	0.01	0.01	0.01	0.01	0.00	0.90
Inventory Turnover	0.01	0.02	0.01	0.10	0.51	1.42
Quick Ratio	0.00	0.00	0.02	0.01	0.06	0.04
Current Ratio	0.01	0.01	0.04	0.03	0.08	0.09
Return on Assets (ROA)	-593.51%	-686.68%	-623.82%	-501.40%	-289.55%	-673.76%
Return on Capital Employed (ROCE)	12.00%	12.30%	45.60%	57.90%	42.50%	79.20%
Earnings Yield	-87.45%	-61.72%	-77.62%	-56.80%	-15.82%	-19.88%
FCF Yield	-15.60%	-11.85%	-27.16%	-5.11%	-5.47%	-6.54%
Buyback Yield / Dilution	-7.41%	-12.54%	-13.05%	-22.74%	-19.71%	-11.27%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.